Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Effect of Forex Changes
Change in reported cash caused by exchange-rate movements on foreign-currency balances.
Effect of Forex Changes history
Currency unavailable · from the cash flow
No Effect of Forex Changes data reported for this period type.
Effect of Forex Changes vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 5.16M SEK | -65.5% | — | 387.9% |
| LTM Jun 2026 | $1.81M USD | -181.0% | — | 0.2% | |
| LTM Mar 2026 | $578K USD | +426.6% | — | 0.5% | |
| LTM Mar 2026 | $4K USD | — | — | 0.0% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -65.5% | — | 0.3% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.